Skip to main navigation menu Skip to main content Skip to site footer
×
Español (España) | English
Editorial
Home
Indexing
Original

Continuous Glucose Monitoring – offering empowerment and self-care agency for type 1 diabetes patients

By
Terhi Kangas ,
Terhi Kangas

Vrije Universiteit Brussel, Interface Demography research group. Brussels, Belgium

Search this author on:

PubMed | Google Scholar
Ricardo Ayala ,
Ricardo Ayala

Faculty of Health & Social Sciences. University of The Americas, Chile

Search this author on:

PubMed | Google Scholar

Abstract

Background: Technologies have increasing availability and significance in health care. Self-care tools are promoting “positive medicalization” by enabling patients to reclaim their individual agency in health care. In Type 1 Diabetes treatment, health technology is prominent - Continuous Glucose Monitoring (CGM) has been developed to facilitate management of the disease, while easing the emotional burden.
Objective: The objective of the study was to show how technology-led self-care affects individuals, and more specifically, their relationship with their doctor, when they gain agency over their own health care.
Methods: This paper draws on a quantitative study using data from the Jaeb Center for Health Research (USA); it examines the effects of CGM on patients’ everyday lives right after starting the use, and after 6 and 12 months of use. The data also shed light on the role of CGM in reshaping patient-doctor relationships. ANOVA tests and multiple linear regression analysis were conducted (n=451, female: 55%, male: 45%, age: mean 25,04, SD 15.8).
Results: The use of the CGM gives freedom to users, but the CGM causes hassles in their daily lives after 6 months of use. Socio-demographic factors (education level, gender, age) did not play a significant role in the changing patient–doctor relationship.
Conclusion: Despite the burden technology may cause, CGM seems beneficial by easing diabetes management. Regarding the patient-doctor relationship, users seemed unaware of changes despite the great gain in agency. This case offers a way to shift the focus to a more moderate critique of medicalized technologies.

How to Cite

1.
Kangas T, Ayala R. Continuous Glucose Monitoring – offering empowerment and self-care agency for type 1 diabetes patients. Salud, Ciencia y Tecnología [Internet]. 2023 Oct. 17 [cited 2024 Feb. 24];3:430. Available from: https://revista.saludcyt.ar/ojs/index.php/sct/article/view/430

The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.

Article metrics

Google scholar: See link

Metrics

Metrics Loading ...

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.